Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wellbeing Digital Sciences Inc KONEF

Wellbeing Digital Sciences Inc. is a Canada-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is also supported by a network of North American clinics that provide therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services with a focus on nutraceutical and emerging health care products.


GREY:KONEF - Post by User

Post by AwareInvestoron Aug 04, 2021 8:13am
109 Views
Post# 33647251

KetamineOne Brings Scent-Enabled Virtual Reality To Psychede

KetamineOne Brings Scent-Enabled Virtual Reality To Psychede
KetamineOne Capital appears to be taking a rather novel approach to psychedelic treatments. The firm this morning revealed that it has signed an exclusive agreement to bring virtual reality to the treatment options the firm provides, with the tech further enhanced by providing an “olfactory-enabled” experience.
<< Previous
Bullboard Posts
Next >>